Financhill
Back

Zevra Therapeutics Vs. Arcutis Biotherapeutics Industry Stock Comparison

Buy
53

ZVRA
Zevra Therapeutics

Last Price:
8.06
Seasonality Move:
-17.07%
Sell
39

ARQT
Arcutis Biotherapeutics

Last Price:
10.16
Seasonality Move:
-19.37%
Buy
53
Zevra Therapeutics (ZVRA) is a Buy

Is Zevra Therapeutics a Buy, Sell or Hold?

  • The current Zevra Therapeutics [ZVRA] share price is $8.04. The Score for ZVRA is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • ZVRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $10.15. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ZVRA Stock Price Chart

What is Zevra Therapeutics's stock price today?

  • The Zevra Therapeutics share price today is $8.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight selling pressure.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $10.15
    The current trend is moderately bearish and ARQT is experiencing slight buying pressure.

ZVRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 63.88 Buy
Chaikin Money Flow: -92956 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 49.72 Sell
Chaikin Money Flow: 1424489 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.23 - 10.97) Buy
Bollinger Bands (100): (8.36 - 10.32) Buy

ZVRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.65 Buy
20-day SMA: 7.43 Buy
50-day SMA: 6.97 Buy
200-day SMA: 5.76 Buy
8-day EMA: 7.7 Buy
20-day EMA: 7.46 Buy
50-day EMA: 6.9 Buy
200-day EMA: 5.87 Buy

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.36 Sell
20-day SMA: 10.51 Sell
50-day SMA: 9.91 Buy
200-day SMA: 8.23 Buy
8-day EMA: 10.33 Sell
20-day EMA: 10.26 Sell
50-day EMA: 9.92 Buy
200-day EMA: 8.97 Buy

Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.29 per share, a decrease this year of $0.32 per share, and an increase next year of $0.99 per share.

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.

Zevra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):